Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2021 Filed Aug 11, 2021 13:15 UTC |
USMAN NASSIMDirector · President & CEO
|
PurchaseCommon Stock | 867 | $3.62 | $3,138.54 |
DisclosureSEC source: 0001209191-21-050759 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,041 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2021. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 13:14 UTC |
Levy HowardChief Medical Officer
|
PurchaseCommon Stock | 639 | $3.62 | $2,313.18 |
DisclosureSEC source: 0001209191-21-050758 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2021. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 13:13 UTC |
Blouse Grant E.Chief Scientific Officer
|
PurchaseCommon Stock | 1,163 | $3.62 | $4,210.06 |
DisclosureSEC source: 0001209191-21-050757 · doc4.xml · nonDerivative · entry 1 Blouse Grant E. · CIK 0001869883 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,917 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2021. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:56 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044693 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,516 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:54 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 2,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044691 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,077 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:54 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 5,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044690 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,734 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:51 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 3,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044688 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,213 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:53 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 2,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044689 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,883 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:56 UTC |
Williams EddieDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044693 · doc4.xml · derivative · entry 2 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:55 UTC |
TETLOW SHARONDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044692 · doc4.xml · derivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:54 UTC |
Ling Geoffrey M.D.Director
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044691 · doc4.xml · derivative · entry 2 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:54 UTC |
LAWLOR AUGUSTINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044690 · doc4.xml · derivative · entry 3 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:51 UTC |
DESOUZA ERROL BDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044688 · doc4.xml · derivative · entry 2 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| June 09, 2021 Filed Jul 2, 2021 13:53 UTC |
Hunt AndreaDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-21-044689 · doc4.xml · derivative · entry 2 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 14:55 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0001209191-21-025783 · doc4.xml · derivative · entry 4 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,783 Underlying: Common Stock · 5,000 shares Expires 2027-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Option vests monthly over a period of four years commencing June 15, 2017. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 14:55 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $4.63 | $23,150.00 |
DisclosureSEC source: 0001209191-21-025783 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:41 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025037 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,102 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:38 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 4,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025032 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,192 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:39 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 2,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025035 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,364 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:37 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 2,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025030 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,997 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:37 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 2,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025028 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,807 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| February 09, 2021 Filed Feb 23, 2021 02:33 UTC |
Levy HowardChief Medical Officer
|
PurchaseCommon Stock | 1,670 | $4.81 | $8,032.70 |
DisclosureSEC source: 0001209191-21-013036 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Howard and Gillian Levy Revocable Trust dated November 21, 1994 Disclosed balance after: 23,390 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 23, 2021 02:33 UTC |
USMAN NASSIMDirector · President & CEO
|
PurchaseCommon Stock | 582 | $4.81 | $2,799.42 |
DisclosureSEC source: 0001209191-21-013037 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,174 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:51 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-009355 · doc4.xml · derivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing February 8, 2021. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:50 UTC |
Musil ClintonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-009351 · doc4.xml · derivative · entry 1 Musil Clinton · CIK 0001779886 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing February 8, 2021. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:50 UTC |
Levy HowardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-009347 · doc4.xml · derivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing February 8, 2021. Read SEC document |
| February 08, 2021 Filed Apr 26, 2021 21:39 UTC Amendment |
USMAN NASSIMDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-028358 · doc4a.xml · derivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests and will become exercisable monthly over 48 months, with 25% of the shares vesting on the 12-month anniversary of the date hereof, and the remainder vesting monthly thereafter at the rate of 1/48th of the total number of shares. Read SEC document |
| February 08, 2021 Filed Apr 26, 2021 21:38 UTC Amendment |
Musil ClintonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 54,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-028356 · doc4a.xml · derivative · entry 1 Musil Clinton · CIK 0001779886 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests and will become exercisable monthly over 48 months, with 25% of the shares vesting on the 12-month anniversary of the date hereof, and the remainder vesting monthly thereafter at the rate of 1/48th of the total number of shares. Read SEC document |
| February 08, 2021 Filed Apr 26, 2021 21:38 UTC Amendment |
Levy HowardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-21-028355 · doc4a.xml · derivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-08 F1 · derivative.exercise_date: Award vests and will become exercisable monthly over 48 months, with 25% of the shares vesting on the 12-month anniversary of the date hereof, and the remainder vesting monthly thereafter at the rate of 1/48th of the total number of shares. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 22:01 UTC |
Williams EddieDirector
|
GrantCommon Stock | 940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002169 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,887 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:58 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 1,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002163 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,033 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:57 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002162 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,431 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:56 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002161 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,517 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:47 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 2,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002150 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,881 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:23 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053132 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,947 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:22 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 2,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053130 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,251 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:19 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 5,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053123 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,014 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:18 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 2,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053119 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,636 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:17 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053117 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,752 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:12 UTC |
USMAN NASSIMDirector · President & CEO
|
PurchaseCommon Stock | 582 | $4.81 | $2,799.42 |
DisclosureSEC source: 0001209191-20-046348 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 10, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:11 UTC |
Levy HowardChief Medical Officer
|
PurchaseCommon Stock | 1,768 | $4.81 | $8,504.08 |
DisclosureSEC source: 0001209191-20-046347 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 F1 · shares: Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 10, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:51 UTC |
Musil ClintonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001209191-20-040433 · doc4.xml · derivative · entry 1 Musil Clinton · CIK 0001779886 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-07-01 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2020, and 1/48 of the shares subject to the option will vest on each monthly anniversary thereafter. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:47 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040412 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,567 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:46 UTC |
TETLOW SHARONDirector
|
GrantCommon Stock | 1,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040405 · doc4.xml · nonDerivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,635 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:45 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 1,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040397 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,635 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:43 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 3,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040391 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,215 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:42 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040386 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,875 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:41 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 2,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040377 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,627 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:49 UTC |
Williams EddieDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036319 · doc4.xml · derivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:48 UTC |
TETLOW SHARONDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036316 · doc4.xml · derivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.